Fetal Aneuploidy clinical trials at University of California Health
1 research study open to eligible people
open to eligible females ages 18 years and up
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
Our lead scientists for Fetal Aneuploidy research studies include Andrew Hull, MD.